Intratumoral Heterogeneity Determines the Expression of mTOR-pathway Proteins in Prostate Cancer

<div>Sites of the samples in relation to the tumor area (red hatches) with the corresponding dots displayed on the TMA carrier. Tumor zone (sample A, black dot), malignant tissue of the tumor invasion front (sample B, green dot), benign tissue adjacent to the tumor invasion front (sample C, blue dot), and benign tissue (sample D, red dot). Hematoxylin-eosin-stained slide.</div>

Disease Markers

fig1

Figure 1

Figure 1: Intratumoral Heterogeneity Determines the Expression of mTOR-pathway Proteins in Prostate Cancer 